Active, not recruitingNot applicableNCT02867033
National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)
Studying Desmoid tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Oscar Lambret
- Principal Investigator
- Nicolas PENEL, PhDCentre Oscar Lambret
- Intervention
- biopsy(procedure)
- Enrollment
- 628 enrolled
- Eligibility
- All sexes
- Timeline
- 2016 – 2030
Study locations (30)
- Institut de Cancérologie de l'Ouest - Paul Papin, Angers, France
- CHU Angers, Angers, France
- CHU de Besançon, Besançon, France
- Hôpital des Enfants, Bordeaux, France
- Institut Bergonié, Bordeaux, France
- CHU de Caen-Côte de Nacre, Caen, France
- Centre François Baclesse, Caen, France
- Centre Jean Perrin, Clermont-Ferrand, France
- Centre Georges François Leclerc, Dijon, France
- CHU de Grenoble- Hôpital Couple Enfant, Grenoble, France
- Centre Oscar Lambret, Lille, France
- Centre Léon Bérard, Lyon, France
- Hôpital la Timone Enfants Service Oncologie Pédiatrique, Marseille, France
- Hôpital la Timone Service Oncologie Médicale, Marseille, France
- Institut Paoli Calmettes, Marseille, France
- +15 more locations on ClinicalTrials.gov
Collaborators
Ligue contre le cancer, France · Institut Curie · Hôpital de la Timone · SOS Desmoid e.V. · APICIL funding · GIRCI NO · UNICANCER · Groupement Interrégional de Recherche Clinique et d'Innovation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02867033 on ClinicalTrials.govOther trials for Desmoid tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07541430A Study in Adults With Desmoid TumorsElpiscience (Suzhou) Biopharma, Ltd.
- RECRUITINGPHASE4NCT07176689Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- ACTIVE NOT RECRUITINGPHASE2NCT07170644A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- RECRUITINGNCT06945887Treatment of Desmoid Fibromatosis With Arterial EmbolizationIstituto Ortopedico Rizzoli
- RECRUITINGNCT07496242Immunological Phenotype of Desmoid-fibromatosis-affected Patients.Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- RECRUITINGPHASE2NCT05879146Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical StudyM.D. Anderson Cancer Center
- RECRUITINGNCT06660121Electrochemotherapy for Desmoid TumorsIstituto Ortopedico Rizzoli
- RECRUITINGNANCT06081400Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful WaitingUniversity Hospital, Strasbourg, France